annb0t
Top 20
ResMed Inc (NYSE:RMD) showcases robust revenue growth with a 12% increase in net revenue for Q3 FY2024. Despite a slight dip in gross margin, RMD maintains a strong gross profit, signaling resilience in operations. Investment in R&D and strategic acquisitions position RMD for sustained innovation and market expansion. Challenges include field safety notifications and competitive pressures in the respiratory care device industry.
Warning! GuruFocus has detected 2 Warning Sign with RMD.
On Janua...
>>> Read more: Decoding ResMed Inc (RMD): A Strategic SWOT Insight
Warning! GuruFocus has detected 2 Warning Sign with RMD.
On Janua...
>>> Read more: Decoding ResMed Inc (RMD): A Strategic SWOT Insight
